Could the Czech Republic’s major IHDC market end with a ban on HHC sales?

The Ministry of Health in the Czech Republic has unveiled plans to ban the sale of hexahydrocannabinol (HHC) this July, triggering criticism from a wide range of local industry insiders, and potentially ending the country’s position as a major market for intoxicating hemp-derived cannabinoids (IHDCs).

The proposal to include HHC on the list of addictive substances is supported by the National Anti-Drug Headquarters (a department within the police) together with the Ministry of Defense and customs officials.

Read full article
I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization